About NeoGen Labs
NeoGen Labs is a Healthcare company based in Bengaluru (India) founded in 2006 by Thomas Mookken. It operates as a neonatal diagnostic solutions for the detection of inborn errors of metabolism. NeoGen Labs has raised $453.14 thousand across 4 funding rounds from investors including Bhagwati Spherocast, Nihal George and Aanal Bhagwati. The company has 25 employees. NeoGen Labs has completed 1 acquisition, including Lab M. NeoGen Labs was last valued at $977.49 thousand in March 2011. Its chief executive is Thomas Mookken. Its Indian entity Neogen Labs Private Limited reported revenue of ₹7.62 Cr. NeoGen Labs offers products and services including First Step Newborn Screening. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Natera, Metabolon, Progenity, SYNLAB and Blueprint Genetics and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
NeoGen Labs develops neonatal diagnostic solutions for the detection of inborn errors of metabolism (IEM). Its flagship product First Step Newborn Screening program is a metabolomics assay that tests for 47 IEM disorders using tandem mass spectrometry (MSMS). The assay is based on the American College of Medical Genetics (ACMG) Core and Secondary panels. The technology has been licensed from PerkinElmer Genetics.
- Headquarters Bengaluru, India
- Employees 25
- Founders Thomas Mookken
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website neogenlabs.com
- Social LinkedIn X Facebook
- Legal Name Neogen Labs Private Limited
- Date of Incorporation 29 Jun, 2006
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹7.62 Cr
FY 2025 · +7% YoY
- Net Loss-₹2.1 Lakh
FY 2025 · 0% margin
- EBITDA₹54.8 Lakh
FY 2025 · 7% margin
- Total Equity Funding$453.14K (USD)
in 4 rounds
- Latest Funding Round$55.63K (USD), Angel Round
Mar 2011
- InvestorsBhagwati Spherocast
& 17 more
- Employee Count25
- Investments & Acquisitions
Associated legal entities of NeoGen Labs
NeoGen Labs operates through Neogen Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neogen Labs Private Limited CIN U33125GJ2006PTC048588 | Active | 29 Jun 2006 | Ahmedabad, Gujarat | ₹7.6 Cr | 25 | 2 | View details |
Products & Services of NeoGen Labs
NeoGen Labs offers a comprehensive portfolio of products and services, including First Step Newborn Screening.
Test to detect metabolic disorders in newborns
Funding Insights of NeoGen Labs
NeoGen Labs has successfully raised a total of $453.14K across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $55.63 thousand completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $453,144
- Total Rounds 4
- Last Round Angel Round — $55,626
- First Round $230,690
(Mar 2007)
- Investors Count 18
All 4 funding rounds of NeoGen Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $55,626 | Angel Round | $977,485 | Nihal George | |
| Apr 2009 | $89,109 | Seed | – | Bhagwati Spherocast | |
| Mar 2008 | $77,719 | Angel Round | – | Kannan Arumugam | |
| Mar 2007 | $230,690 | Seed | $788,028 | Bhagwati Spherocast, Pravin Bhagwati |
Last known valuation $977,485 (Mar 2011). 18 investors in total: 1 institutional and 17 angel.
Investors in NeoGen Labs
NeoGen Labs has secured backing from 18 investors, including angel and institutional investors. Prominent investors backing the company include Bhagwati Spherocast, Nihal George and Aanal Bhagwati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Control system components manufactured for tier 1 suppliers and OEMs. | 1977 | bhagwati.com | Ahmedabad, India | |
NG Nihal George | - | – | unknown_46cb39eb634449c89 | - |
AB Aanal Bhagwati | - | – | unknown_8ad0c7db6db64ee6b | - |
MB Mandakini Bhagwati | - | – | unknown_4bcc7ecdf5ef4c069 | - |
AC Arti Chaterjee | - | – | unknown_2884250584e14faab | - |
PB Pravin Bhagwati | - | – | unknown_fe4a38d193ff4254b | - |
KA Kannan Arumugam | - | – | unknown_e3bbd2124039457da | - |
SP Sanjay Puri | - | – | unknown_9802892447fe41fea | - |
SD Sunil Dhingra | - | – | unknown_b14f6a90a9964cff9 | - |
SM Swetha Muthanna | - | – | unknown_d07bd081c2f14bae9 | - |
Investor details for NeoGen Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Neogen Labs Private Limited (NeoGen Labs)
Neogen Labs Private Limited is the primary company behind NeoGen Labs. The board of Neogen Labs Private Limited currently have 2 directors; the longest-serving is Aanal Pravin Bhagwati, appointed in 2006. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aanal Pravin Bhagwati DIN 00125028 | Director | 29 Jun 2006 | 20 yrs 3 mo | Neogen Labs Private Limited |
| Pravin Natvarlal Bhagwati DIN 00096799 | Director | 02 Dec 2013 | 12 yrs 10 mo | Neogen Labs Private Limited |
People of NeoGen Labs
1 people are tracked at NeoGen Labs (1 in leadership); the tracked headcount is 25.
| Name | Role | Group |
|---|---|---|
Thomas Mookken | Co-Founder & CEO | Leadership |
Complete people profiles for NeoGen Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NeoGen Labs
Figures of Neogen Labs Private Limited, the primary company behind NeoGen Labs, for FY 2025. Revenue was ₹7.62 Cr (+7% year on year). Net loss was -₹2.1 Lakh (0% margin). EBITDA was ₹54.8 Lakh (7% margin). Revenue has grown at a compounded annual rate of 0% over three years and -9% over five years.
- ₹7.62 CrRevenue · FY 2025 · +7% YoY
- -₹2.1 LakhNet loss · 0% margin
- ₹54.8 LakhEBITDA · 7% margin
- ₹4.4 LakhPaid-up capital
- 25Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neogen Labs Private Limited are on its company page.
Detailed financial statements for NeoGen Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeoGen Labs
NeoGen Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lab M.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufactures microbiology products | labm.com | Heywood, United Kingdom | 1971 | Aug 2015 | •••• |
Complete acquisition details for NeoGen Labs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NeoGen Labs
4 dated milestones of NeoGen Labs across 9 years, from founding to its latest funding, stage changes and deals.
- Founded NeoGen Labs is founded.
- Funding First funding round of $231K.
- Funding Latest funding round, Angel Round, of $56K.
- Acquisition Acquires Lab M.
Competitors of NeoGen Labs
NeoGen Labs has 10 listed competitors in our database, 7 of them funded. They include Natera, Metabolon, Progenity, SYNLAB and Blueprint Genetics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| progenity.com | 2011 | San Diego, United States | $216.63M | 125 | Non-invasive prenatal genomic testing is provided for genetic disorders. | |
| synlab.com | 1998 | Munich, Germany | – | 28,693 | Provider of medical diagnosis and clinical laboratory analysis services | |
| blueprintgenetics.com | 2012 | Espoo, Finland | $19.86M | – | Genetic diagnostics and clinical interpretation for hereditary diseases are provided. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| yourgene-health.com | 2000 | Manchester, United Kingdom | – | 2 | Non-invasive prenatal genetic tests and genomic services are provided. | |
| 3billion.io | 2016 | Seoul, South Korea | $25.69M | – | AI-driven diagnostic platform for rare genetic diseases is offered. | |
| ascelia.com | 2000 | Malmo, Sweden | $6.92M | – | Developer of orphan drugs for treatment and diagnostics solutions | |
| sequenom.com | 1994 | San Diego, United States | – | 524 | Noninvasive prenatal testing using cell-free fetal nucleic acids is offered. |
Detailed competitors of NeoGen Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as NeoGen Labs (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NeoGen Labs
NeoGen Labs was founded in 2006 and raised its 1st funding round 1 year after it was founded.
NeoGen Labs is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Thomas Mookken is the current CEO of NeoGen Labs. They have also founded this company.
NeoGen Labs is a funded company, having raised a total of $453.14K across 4 funding rounds to date. The company's 1st funding round was a Seed of $230.69K, raised on Mar 2007.
NeoGen Labs has 25 employees.
The primary company behind NeoGen Labs, Neogen Labs Private Limited, reported revenue of ₹7.62 Cr for FY 2025, up 7% year on year.
NeoGen Labs develops neonatal diagnostic solutions for the detection of inborn errors of metabolism (IEM). Its flagship product First Step Newborn Screening program is a metabolomics assay that tests for 47 IEM disorders using tandem mass spectrometry (MSMS). The assay is based on the American College of Medical Genetics (ACMG) Core and Secondary panels. The technology has been licensed from PerkinElmer Genetics.
NeoGen Labs offers First Step Newborn Screening.
NeoGen Labs has made 1 acquisition, including Lab M.
NeoGen Labs has 18 investors. Key investors include Bhagwati Spherocast, Nihal George, Aanal Bhagwati, Mandakini Bhagwati, and Arti Chaterjee.
The valuation of NeoGen Labs is $977.49K as of Mar 2011.